No Picture
Trading Ideas

AIG posts quarterly profit as catastrophe losses drop

Insurer American International Group Inc on Friday posted a profit in the third quarter, compared with a year-earlier loss when it recorded more than a billion dollars in catastrophe losses. AIG’s net income attributable to common shareholders was $648 million, or 72 cents per share, in the third quarter ended Sept. 30, compared with a loss $1.26 billion, or $1.41 per share, a year earlier. …read more […]

No Picture
Trading Ideas

Trade Alert: The Executive VP and President of Commercial & Specialty Business Division Of Anthem, Inc. (NYSE:ANTM), Peter Haytaian, Has Sold Some Shares Recently

We wouldn’t blame Anthem, Inc. (NYSE:ANTM) shareholders if they were a little worried about the fact that Peter… …read more […]

No Picture
Trading Ideas

UPDATE 1-Novartis arthritis drug falls short in challenge to global bestseller

ZURICH/FRANKFURT, Nov 1 (Reuters) – Novartis said a trial fell short of producing statistical evidence that its anti-inflammatory drug Cosentyx can beat the world’s best-selling drug Humira in treating a type of arthritis. The Swiss pharma giant said on Friday that Cosentyx, used in a trial to treat active psoriatic arthritis, yielded “numerically higher results versus Humira” but the statistical readout was not reliable enough to count as evidence. The Swiss group said that Cosentyx, its second-bestselling drug with $2.8 billion in revenue last year, “narrowly missed statistical significance for superiority” over Humira, a drug made by AbbVie.. …read more […]